These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

652 related items for PubMed ID: 16837887

  • 1. Different effects of oral conjugated equine estrogens and transdermal estrogen on undercarboxylated osteocalcin concentration in postmenopausal women.
    Yasui T, Uemura H, Tomita J, Umino Y, Yamada M, Kuwahara A, Matsuzaki T, Maegawa M, Miura M, Irahara M.
    Menopause; 2006; 13(4):651-9. PubMed ID: 16837887
    [Abstract] [Full Text] [Related]

  • 2. Undercarboxylated osteocalcin concentration in postmenopausal women receiving hormone therapy daily and on alternate days.
    Yasui T, Uemura H, Umino Y, Yamada M, Kuwahara A, Matsuzaki T, Maegawa M, Furumoto H, Miura M, Irahara M.
    Menopause; 2006; 13(2):314-22. PubMed ID: 16645545
    [Abstract] [Full Text] [Related]

  • 3. [Clinical application of undercarboxylated osteocalcin].
    Yasui T, Yamada M, Irahara M.
    Clin Calcium; 2007 Nov; 17(11):1709-16. PubMed ID: 17982191
    [Abstract] [Full Text] [Related]

  • 4. Effects of transdermal and oral estrogen replacement on lipids and glucose metabolism in postmenopausal women with type 2 diabetes mellitus.
    Araújo DA, Farias ML, Andrade AT.
    Climacteric; 2002 Sep; 5(3):286-92. PubMed ID: 12419087
    [Abstract] [Full Text] [Related]

  • 5. Effects of four different regimens of hormone replacement therapy on hemostatic parameters: a prospective randomized study.
    Taner MZ, Ozpolat E, Taskiran C, Onan MA, Gursel T, Karabulut E, Gursoy R, Himmetoglu O.
    Maturitas; 2006 Feb 20; 53(3):267-73. PubMed ID: 15978753
    [Abstract] [Full Text] [Related]

  • 6. Effect of lower dose of oral conjugated equine estrogen on size and oxidative susceptibility of low-density lipoprotein particles in postmenopausal women.
    Wakatsuki A, Okatani Y, Ikenoue N, Shinohara K, Watanabe K, Fukaya T.
    Circulation; 2003 Aug 19; 108(7):808-13. PubMed ID: 12900341
    [Abstract] [Full Text] [Related]

  • 7. Tibolone, transdermal estradiol or oral estrogen-progestin therapies: effects on circulating allopregnanolone, cortisol and dehydroepiandrosterone levels.
    Pluchino N, Genazzani AD, Bernardi F, Casarosa E, Pieri M, Palumbo M, Picciarelli G, Gabbanini M, Luisi M, Genazzani AR.
    Gynecol Endocrinol; 2005 Mar 19; 20(3):144-9. PubMed ID: 16019353
    [Abstract] [Full Text] [Related]

  • 8. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
    Stanosz S, Zochowska E, Safranow K, Sieja K, Stanosz M.
    Metabolism; 2009 Jan 19; 58(1):1-7. PubMed ID: 19059524
    [Abstract] [Full Text] [Related]

  • 9. Effect of vitamin K2 treatment on carboxylation of osteocalcin in early postmenopausal women.
    Yasui T, Miyatani Y, Tomita J, Yamada M, Uemura H, Miura M, Irahara M.
    Gynecol Endocrinol; 2006 Aug 19; 22(8):455-9. PubMed ID: 17012108
    [Abstract] [Full Text] [Related]

  • 10. Quality of life assessment in a chemoprevention trial: fenretinide and oral or transdermal HRT.
    Serrano D, Mariani L, Mora S, Guerrieri-Gonzaga A, Cazzaniga M, Daldoss C, Ramazzotto F, Feroce I, Decensi A, Bonanni B.
    Maturitas; 2006 Aug 20; 55(1):69-75. PubMed ID: 16500052
    [Abstract] [Full Text] [Related]

  • 11. [Comparative study on two different dosages of conjugated equine estrogen continuously combined with medroxyprogesterone in prevention of postmenopausal osteoporosis].
    Wu Y, Liu J, Xing S, Xu R, Zhang Z, Wang Y.
    Zhonghua Fu Chan Ke Za Zhi; 2002 May 20; 37(5):267-70. PubMed ID: 12133397
    [Abstract] [Full Text] [Related]

  • 12. Serum estrogen level after hormone replacement therapy and body mass index in postmenopausal and bilaterally ovariectomized women.
    Yasui T, Uemura H, Umino Y, Takikawa M, Saito S, Kuwahara A, Matsuzaki T, Maegawa M, Furumoto H, Miura M, Irahara M.
    Maturitas; 2005 Jan 10; 50(1):19-29. PubMed ID: 15590210
    [Abstract] [Full Text] [Related]

  • 13. A comparison of the effects of raloxifene and conjugated equine estrogen on bone and lipids in healthy postmenopausal women.
    Reid IR, Eastell R, Fogelman I, Adachi JD, Rosen A, Netelenbos C, Watts NB, Seeman E, Ciaccia AV, Draper MW.
    Arch Intern Med; 2004 Apr 26; 164(8):871-9. PubMed ID: 15111373
    [Abstract] [Full Text] [Related]

  • 14. Comparison of continuation of postmenopausal hormone replacement therapy: transdermal versus oral estrogen.
    Ettinger B, Pressman A, Bradley C.
    Menopause; 1998 Apr 26; 5(3):152-6. PubMed ID: 9774760
    [Abstract] [Full Text] [Related]

  • 15. Serum androgen levels and insulin resistance in postmenopausal women: association with hormone therapy, tibolone and raloxifene.
    Christodoulakos G, Lambrinoudaki I, Panoulis C, Sioulas V, Rizos D, Caramalis G, Botsis D, Creatsas G.
    Maturitas; 2005 Apr 11; 50(4):321-30. PubMed ID: 15780533
    [Abstract] [Full Text] [Related]

  • 16. Effects of estrogen, raloxifene, and hormone replacement therapy on serum C-reactive protein and homocysteine levels.
    Gol M, Akan P, Dogan E, Karas C, Saygili U, Posaci C.
    Maturitas; 2006 Feb 20; 53(3):252-9. PubMed ID: 15990257
    [Abstract] [Full Text] [Related]

  • 17. Serum estradiol concentration as measured by HPLC-RIA and bone mineral density in postmenopausal women during hormone replacement therapy.
    Yasui T, Uemura H, Umino Y, Takikawa M, Kuwahara A, Saito S, Matsuzaki T, Maegawa M, Furumoto H, Miura M, Irahara M.
    Horm Res; 2004 Feb 20; 61(3):117-25. PubMed ID: 14676459
    [Abstract] [Full Text] [Related]

  • 18. Change in serum undercarboxylated osteocalcin concentration in bilaterally oophorectomized women.
    Yasui T, Uemura H, Tomita J, Miyatani Y, Yamada M, Kuwahara A, Matsuzaki T, Maegawa M, Miura M, Irahara M.
    Maturitas; 2007 Mar 20; 56(3):288-96. PubMed ID: 17030103
    [Abstract] [Full Text] [Related]

  • 19. Reduced vaginal bleeding in postmenopausal women who receive combined norethindrone acetate and low-dose ethinyl estradiol therapy versus combined conjugated equine estrogens and medroxyprogesterone acetate therapy.
    Simon JA, Liu JH, Speroff L, Shumel BS, Symons JP.
    Am J Obstet Gynecol; 2003 Jan 20; 188(1):92-9. PubMed ID: 12548201
    [Abstract] [Full Text] [Related]

  • 20. Effect of different preparations of hormone therapy on lipid and glucose metabolism, coagulation factors, and bone mineral density in overweight and obese postmenopausal women.
    Osmanağaoğlu MA, Osmanağaoğlu S, Osmanağaoğlu T, Okumuş B, Bozkaya H.
    Fertil Steril; 2005 Aug 20; 84(2):384-93. PubMed ID: 16084879
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.